
A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen
Keywords: PIKA adjuvant; Rabies vaccine; Immunogenicity; Safety; TLR3; Phase II; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CIRB; Centralised Institutional Review Board; CSIRO; Commonwealth Scientific and Industr